We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
Cap. Flow
-$941M
Cap. Flow %
-3.95%
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 30.74%
2 Financials 13.54%
3 Consumer Discretionary 13.12%
4 Industrials 11.88%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
301
CME Group
CME
$91.6B
$10.5M 0.04%
+35,414
New +$10.5M
MSGE icon
302
Madison Square Garden
MSGE
$3.64B
$10.4M 0.04%
175,812
+7,392
+4% +$437K
WMG icon
303
Warner Music
WMG
$13.9B
$10.3M 0.04%
404,277
-553
-0.1% -$15.7K
RHI icon
304
Robert Half
RHI
$3.96B
$10.2M 0.04%
400,119
-1,679,504
-81% -$44.4M
AIP icon
305
Arteris
AIP
$1.53B
$9.99M 0.04%
607,626
+382,931
+170% +$6.07M
JPM icon
306
JPMorgan Chase
JPM
$924B
$9.92M 0.04%
33,713
-27,589
-45% -$8.37M
CVI icon
307
CVR Energy
CVI
$3.4B
$9.77M 0.04%
290,455
-991,462
-77% -$25.5M
ALGM icon
308
Allegro MicroSystems
ALGM
$9.43B
$9.71M 0.04%
+308,102
New +$10.6M
NRIX icon
309
Nurix Therapeutics
NRIX
$2.47B
$9.62M 0.04%
620,820
-114,354
-16% -$1.9M
ACMR icon
310
ACM Research
ACMR
$6.06B
$9.61M 0.04%
+244,252
New +$13M
BCRX icon
311
BioCryst Pharmaceuticals
BCRX
$2.38B
$9.56M 0.04%
1,004,373
-27,115
-3% -$211K
NXT icon
312
Nextpower Inc
NXT
$15.8B
$9.53M 0.04%
79,054
-18,152
-19% -$2.01M
ASTH icon
313
Astrana Health
ASTH
$2.04B
$9.48M 0.04%
386,424
-87,290
-18% -$2.07M
PRTA icon
314
Prothena Corp
PRTA
$447M
$9.45M 0.04%
972,017
-5,994
-0.6% -$54.9K
HRTG icon
315
Heritage Insurance Holdings
HRTG
$795M
$9.42M 0.04%
358,682
+14,938
+4% +$394K
MYGN icon
316
Myriad Genetics
MYGN
$538M
$9.4M 0.04%
2,088,492
-181,886
-8% -$948K
RCUS icon
317
Arcus Biosciences
RCUS
$3.77B
$9.3M 0.04%
430,346
-499,635
-54% -$10.8M
PB icon
318
Prosperity Bancshares
PB
$8.68B
$9.22M 0.04%
137,211
-14,944
-10% -$1.05M
GRND icon
319
Grindr
GRND
$2.59B
$9.18M 0.04%
759,445
-311,425
-29% -$3.67M
OSPN icon
320
OneSpan
OSPN
$547M
$9.13M 0.04%
867,337
+218,135
+34% +$2.47M
GEV icon
321
GE Vernova
GEV
$276B
$9.03M 0.04%
+10,349
New +$8.07M
PHR icon
322
Phreesia
PHR
$608M
$9.01M 0.04%
1,075,760
+176,662
+20% +$2.34M
ETD icon
323
Ethan Allen Interiors
ETD
$568M
$9M 0.04%
404,145
+8,682
+2% +$202K
ROG icon
324
Rogers Corp
ROG
$2.37B
$8.99M 0.04%
83,723
+31,196
+59% +$3.21M
BBSI icon
325
Barrett Business Services
BBSI
$974M
$8.79M 0.04%
301,104
+99,753
+50% +$3.3M

Similar funds

Jacobs Levy Equity Management's Q1 2026 Portfolio in Review

As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.

  • Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
  • Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
  • Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
  • Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
  • Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
  • Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.